ARTICLE | Clinical News
Tretinoin intravenous all-trans retinoic acid: GENZ began a Phase II/III trial
December 12, 1994 8:00 AM UTC
Genzyme Corp. (GENZ), Cambridge, Mass. Argus Pharmaceuticals Inc. (ARGS), The Woodlands, Texas Product: Tretinoin intravenous all-trans retinoic acid (ATRA) in liposomes Indication: Kaposi's sarcoma ...